Wuhan Kangzhu Biotechnology Co., Ltd.
Wuhan Pearl Biotechnology produces and sells in vitro diagnostic reagents, passed GMP certification, offering products in multiple lines for various medical tests.
Introduction
Wuhan Pearl Biotechnology Co., Ltd. specializes in the development, production, and sales of in vitro diagnostic reagents. It is the pioneering institution in China to achieve GMP certification by the National Food and Drug Administration. The company's comprehensive product system includes enzyme-linked immunosorbent assays (ELISAs), glucose measurements, biochemical tests, chemical analyses, and radiation assessment, encompassing a wide range of applications such as infectious disease diagnosis, tumor screening, and women's health testing.
More Websites
Two subsidiaries are organized with Ciba Holding Deutschland GmbH as the parent, supported by the holding and Business Support Group.